Search Within

Christopher Jon Forlenza

  1. "Immunology Program Faculty"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Center for Hematologic Malignancies (5)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (5)
  3. Department of Medicine (5)
  4. GSK Faculty (5)
  5. Hematologic Malignancies Service (5)
  6. Immunology Program Faculty (5)

More Groups

People
  1. Neerav Shukla (5)
  2. Richard O'Reilly (5)
  3. Andrew Kung (4)
  4. Farid Boulad (4)
  5. Kevin Curran (4)
  6. Nancy Kernan (4)

More People

Years
  1. 2021 (1)
  2. 2019 (1)
  3. 2017 (2)
  4. 2014 (1)
Publications
  1. Blood (3)
  2. Biology of Blood and Marrow Transplantation (1)
  3. Nature Cancer (1)
Publishers
  1. American Society of Hematology (3)
  2. Elsevier Inc. (1)
  3. Nature Research (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
    Journal Article

    Fiala, E. M.; Jayakumaran, G.; Mauguen, A.; Kennedy, J. A.; Bouvier, N.; Kemel, Y.; Fleischut, M. H.; Maio, A.; Salo-Mullen, E. E.; Sheehan, M.; more...
    Nature Cancer (2021)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Brentuximab vedotin plus bendamustine is an effective salvage regimen for pediatric patients with relapsed Hodgkin lymphoma
    Meeting Abstract

    Gulati, N.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jackson, C.; Kernan, N.; Kung, A. L.; O'Reilly, R.; Prockop, S.; Ramaswamy, K.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Busulfan, melphalan, and thiotepa conditioning for allogeneic hematopoietic stem cell transplantation (HSCT) of pediatric patients with acute leukemia and central nervous system (CNS) disease
    Meeting Abstract

    Forlenza, C. J.; Kobos, R.; Kernan, N. A.; Scaradavou, A.; Prockop, S. E.; Curran, K.; Shukla, N.; Steinherz, P. G.; O'reilly, R.; Boulad, F.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save